Denali Therapeutics (DNLI) Long-Term Investments (2017 - 2025)
Historic Long-Term Investments for Denali Therapeutics (DNLI) over the last 9 years, with Q3 2025 value amounting to $24.7 million.
- Denali Therapeutics' Long-Term Investments fell 9445.45% to $24.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.7 million, marking a year-over-year decrease of 9445.45%. This contributed to the annual value of $359.4 million for FY2024, which is N/A changed from last year.
- As of Q3 2025, Denali Therapeutics' Long-Term Investments stood at $24.7 million, which was down 9445.45% from $78.5 million recorded in Q2 2025.
- In the past 5 years, Denali Therapeutics' Long-Term Investments registered a high of $490.7 million during Q1 2024, and its lowest value of $7.9 million during Q3 2023.
- For the 5-year period, Denali Therapeutics' Long-Term Investments averaged around $236.7 million, with its median value being $243.1 million (2022).
- As far as peak fluctuations go, Denali Therapeutics' Long-Term Investments soared by 553520.56% in 2024, and later plummeted by 9445.45% in 2025.
- Quarter analysis of 5 years shows Denali Therapeutics' Long-Term Investments stood at $425.4 million in 2021, then tumbled by 77.85% to $94.2 million in 2022, then crashed by 91.61% to $7.9 million in 2023, then surged by 4446.15% to $359.4 million in 2024, then tumbled by 93.13% to $24.7 million in 2025.
- Its Long-Term Investments stands at $24.7 million for Q3 2025, versus $78.5 million for Q2 2025 and $235.8 million for Q1 2025.